ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Energy Storage

Merck KGaA plans Swiss biotech center

by Alex Scott
February 1, 2020 | APPEARED IN VOLUME 98, ISSUE 5

 

Merck KGaA will build a biotech development and manufacturing center in Corsier-sur-Vevey, Switzerland. The 15,700 m2 center will cost $275 million and employ about 250 when it opens in 2022. Merck says the center will enable the cost-effective production of drugs for clinical trials, accelerate biological drug development, and address the increasing complexity of manufacturing next-generation biotech compounds.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment